The device helped T2D patients who need kidney dialysis to maintain normal blood sugar levels.
Eli Lilly has entered into strategic international agreements with four companies to develop connected solutions and simplify care for diabetes patients who use insulin pens in markets outside the US.
While medical markets the world over have been slammed by the Covid-19 pandemic, a precious few have remained resilient and some have even grown. While elective surgeries such as hip…
GlobalData projects that innovation in digital platforms and devices will be critical for long-term type 1 diabetes management and that the app format of Tidepool Loop will be a gamechanger for AID systems.
Researchers from the Netherlands have developed a novel therapy which has been seen to reduce or completely alleviate insulin dependency in a small group of type 2 diabetes patients. The research, presented at UEG Week...
Despite a dipping diabetes tech market stemming from the Covid-19 crisis, Medtronic has netted a guarantee of up to $337m in R&D funding for its diabetes portfolio.